About Conference
OMICS International Conferences invites all the participants from all over the world to attend Annual Conference on Stem Cell and Regenerative Medicine’ during Aug 4-6, 2016 at Manchester, UK, which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Stem cells are cells originate in all multi-cellular organisms. They were isolated in mice in 1981 and in humans in 1998. In humans there are several types of stem cells, each with variable levels of potency. Stem cell treatments are a type of cell therapy that introduces new cells into adult bodies for possible treatment of cancer, diabetes, neurological disorders and other medical conditions. Stem cells have been used to repair tissue damaged by disease or age. Currently it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate (CAGR) of 22.3%. On the basis of geography, Europe hold the second place in the global market in the field of regenerative medicine & tissue engineering. In Europe countries like UK, France and Germany are possessing good market shares in the field of regenerative medicine and tissue engineering. Spain and Italy are the emerging market trends for tissue engineering in Europe.
Objective:
Stem Cell Congress-2016 has the goal to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. World Congress Stem Cell Therapy 2016 will have an anticipated participation of 150+ delegates across the world to discuss the conference goal.
About Organizers:
OMICS International is one of the leading Open Access publishers and organizers of international scientific conferences and events every year across USA, Europe & Asia OMICS Group has so far organized 600+ International Conferences across the World with 700+ peer-reviewed open access journals in basic science, health, and technology. OMICS International is also in association with more than 1000 International scientific and technological societies and associations and a team of 30,000 eminent scholars, reputed scientists as editorial board members.
Scientific Sessions:
Stem Cell Therapy-2016 will encompass recent researches and findings in stem cell technologies, stem cell therapies and transplantations, current understanding of cell plasticity in cancer and other advancements in stem cell research and cell science. Stem Cell Therapy-2015 will be a great platform for research scientists and young researchers to share their current findings in this field of applied science. The major scientific sessions in Stem Cell Therapy-2016 will focus on the latest and exciting innovations in prominent areas of cell science and stem cell research.
Target Audience:
Eminent personalities, Directors, CEO, President, Vice-president, Organizations, Associations heads and Professors, Research scientists, Stem Cell laboratory heads, Post-docs, Students other affiliates related to the area of Stem cell research, stem cell line companies can be as Target Audience.
Conference Highlights
- Stem Cell Therapy
- Stem Cell
- Somatic Cell Therapy
- Tissue Regeneration
- Regeneration and Therapeutics
- Tumour Cell Science
- Stem Cell Biomarkers
- Stem Cell Technologies
- Stem Cell Skin Care
- Stem Cell Apoptosis and Signal Transduction
- Cord Blood and Regenerative Medicine
- Novel Approaches in Guided Tissue Regeneration
- Potential Applications of Stem cell Therapy
- Stem Cell Products
- Regenerative Medicine and Market
- Reprogramming Stem Cells: Computational Biology
Special Issues
- All accepted abstracts will be published in respective OMICS International Journals.
- Abstracts will be provided with Digital Object Identifier by Cross Ref.
See more at: http://stemcell-regenerativemedicine.conferenceseries.com/
